SIRT1: A Potential Therapeutic Target in Autoimmune Diseases

The morbidity and mortality of autoimmune diseases (Ads) have been increasing worldwide, and the identification of novel therapeutic strategies for prevention and treatment is urgently needed. Sirtuin 1 (SIRT1), a member of the class III family of nicotinamide adenine dinucleotide (NAD(+))-dependent...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Pan, Deng, Xuan, Chen, Zhe, Ba, Xin, Qin, Kai, Huang, Ying, Huang, Yao, Li, Tingting, Yan, Jiahui, Tu, Shenghao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650132/
https://www.ncbi.nlm.nih.gov/pubmed/34887866
http://dx.doi.org/10.3389/fimmu.2021.779177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650132/
https://www.ncbi.nlm.nih.gov/pubmed/34887866
http://dx.doi.org/10.3389/fimmu.2021.779177

Ejemplares similares